Navigenics is pleased to announce the acquisition of a clinical testing facility for our genetic testing services. I’d like to share the details about this exciting opportunity, as described in a news release issued today:
Navigenics, a leading personal genomics testing company, announced today the acquisition of the Affymetrix Clinical Services Laboratory, a CLIA-certified testing facility that provides molecular genome scanning using the Affymetrix GeneChip® microarray platform. With the purchase of this testing facility, Navigenics can now offer fully integrated genome screening and analysis under one roof.